Moses Moustakim
Principal Scientist Photys Therapeutics
Seminars
Thursday 30th October 2025
tPRIME: A Novel Induced Proximity Approach to Targeting p53-Y220C Mutant Cancers
9:45 am
Thursday 30th October 2025
Panel Discussion: Exploring the Frontier Beyond Traditional Degradation: Challenges, Opportunities & Emerging Modalities
9:15 am
- Defining key principles for expanding the druggable proteome and identifying targets amenable to novel induced proximity strategies
- Investigating unmet needs where emerging modalities outperform traditional degradation and uncovering new therapeutic niches
- Addressing translational hurdles for novel approaches and highlighting biotech priorities in overcoming delivery, specificity and scalability challenges
- Spotlighting the most exciting new directions in induced proximity, from novel E3 ligases to non-degradative functional modulation
